Rough Draft Atlanta on MSN2h
Researchers expect FDA to approve a twice-yearly shot that reduces risk of HIV infection by 96%Roughly 61,000 Georgians live with HIV, the sexually transmitted virus (STI) that can lead to AIDS, and Atlanta ranks in the ...
WHO is convening a Guideline Development Group (GDG) for the development of new guidelines on the use of injectable ...
A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...
In Donald Trump’s 2019 State of the Union Address, he made “a commitment to eliminate the HIV epidemic in the United States ...
Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...
A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.
A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug ...
However, the drug does not cure existing HIV infection or AIDS, Dr. Colleen Kelley, the lead author of this study, told USA TODAY. Lenacapavir helps prevent HIV infection by disrupting the ...
Wesley Sundquist’s lab laid foundation for development of a highly effective, long-lasting preventive measure against HIV.
Experts are interested in finding the best strategies for HIV prevention, including the best options for pre-exposure prophylaxis. One study revealed that injection of the medication lenacapavir ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback